Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Evolocumab on Platelet Reactivity in Patients With Diabetes Mellitus After Elective Percutaneous Coronary Intervention

NCT03258281 is registered in ClinicalTrials.gov with Inova Health Care Services as lead sponsor.

NCT NCT03258281
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03258281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Evolocumab on Platelet Reactivity in Patients With Diabetes Mellitus After Elective Percutaneous Coronary Intervention
Lead sponsor
Inova Health Care Services
Phase
Phase 4
Overall status
Terminated
Start date
May 1, 2018
Completion date
October 1, 2019
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2, dyslipidemia associated with type ii diabetes mellitus, percutaneous coronary intervention